Company Watch

Flamingo bags CRAMS order from Teva

Our News Bureau - Mumbai

Flamingo Pharmaceuticals, a quality-driven Indian pharmaceutical company with an experience of over two decades in global pharmaceutical markets announced that it has bagged the order from Teva Group to manufacture Zolpidem tartrate tablets for Netherlands market.

Flamingo Pharma has received the initial order to manufacture 10 million 10 mg tablets and would be shipping the first batch of Zolpidem by October 2007. Apart from Zolpidem, Flamingo is also currently manufacturing Verapamil, Zopiclone, Simvastatin, Dipyridamol and Tramadol for Teva. "Zolpidem tartrate tablets are used for the short-term treatment of insomnia and related disorders and have total annual market sales of $12 billion worldwide. Through our association with Teva, we hope to capture substantial share for this product in the European markets," says Ashwin Thacker, Managing Director of Flamingo Pharmaceuticals.

Flamingo manufactures formulations for companies in over 45 countries across five continents. In semi-regulated markets, it has won a staggering 1,842 registrations, one of the highest for Indian companies, for Flamingo branded formulations across markets including Philippines, Vietnam, Sri Lanka, Kenya, Costa Rica, Haiti, Uganda, Hong Kong, and many more. Flamingo also exports to Europe, Central and South America, Africa and the Gulf and supplies to global institutions like International Red Cross Society, World Health Organisation (WHO) and World Bank aided projects.